As a coronary interventional tool, microcatheters support the performance of invasive endovascular procedures by fulfilling a wide range of functions in complex vascular anatomies. Manufacturers across the world are investing in research and development of advanced technologies, which has led to the development of new and advanced products, along with a surge in product approvals. A few product approvals and developments are listed below ; In 2019, Navitian, a new coronary microcatheter from iVascular, received the CE mark approval. The device was approved to facilitate, guide, and support a guidewire while accessing the coronary system, exchanging guidewires, and injecting radiopaque contrast media or saline solutions. In 2020, Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System. FFR measurements assess arterial lesion severity and the intervention strategies in diagnosing and treating coronary artery disease. In May 2023, Acotec Scientific Holdings Ltd. received Chinese marketing approval for its microcatheter Vericor-14 to assist in percutaneous coronary interventions and percutaneous peripheral interventions, taking a step ahead in a competitive market that is poised to grow eightfold by the end of the decade.
Therefore, a surge in new product approvals, launches, and awareness in the field of cardiac microcatheter is expected to fuel the cardiac microcatheter market growth during the forecast period.
The Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region occupies a significant position in the Asia Pacific cardiac microcatheter market and is expected to demonstrate a promising growth trajectory during the forecast period. The driving factors for the growth of the market are increasing prevalence of cardiovascular diseases, growing aging population, improving healthcare infrastructure, and rising awareness about minimally invasive procedures.
Asia Pacific Cardiac Microcatheter Market Segmentation
The Asia Pacific cardiac microcatheter market is segmented into indication, end user, and country.
Based on indication, the Asia Pacific cardiac microcatheter market is segmented into general peripheral vascular and coronary. The coronary segment held a larger share of the Asia Pacific cardiac microcatheter market in 2023.
Based on end user, the Asia Pacific cardiac microcatheter market is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the Asia Pacific cardiac microcatheter market in 2023.
Based on country, the Asia Pacific cardiac microcatheter market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the share of the Asia Pacific cardiac microcatheter market in 2023.
Boston Scientific Corp; Integer Holdings Corp; Medtronic Plc; Merit Medical Systems Inc; Nipro Corp; OrbusNeich Medical Group Holdings Ltd; Teleflex Inc; Terumo Corp; and Tokai Medical Products Inc are the leading companies operating in the Asia Pacific cardiac microcatheter market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 80.47 Million |
| Market Size by 2028 | US$ 114.76 Million |
| CAGR (2023 - 2028) | 7.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Indication
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Cardiac Microcatheter Market is valued at US$ 80.47 Million in 2023, it is projected to reach US$ 114.76 Million by 2028.
As per our report Asia Pacific Cardiac Microcatheter Market, the market size is valued at US$ 80.47 Million in 2023, projecting it to reach US$ 114.76 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia Pacific Cardiac Microcatheter Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Cardiac Microcatheter Market report:
The Asia Pacific Cardiac Microcatheter Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Cardiac Microcatheter Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Cardiac Microcatheter Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)